Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-15T14:35:23.855Z.
Calculation as of: 2026-09-15T14:35:23.855Z.
Quote observation: 2026-09-15T14:34:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 54bacd10f0491fd3a297ad2bd382e527969baf22037c4b97538d42d095a16556
PEG RATIO
N/A
Cardinal Health, Inc.
Market Cap
$54.58B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Cardinal Health, Inc. (CAH) | $54.58B | N/A |
| Moderna, Inc. (MRNA)vs › | $56.81B | N/A |
| Becton, Dickinson and Company (BDX)vs › | $50.22B | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $49.18B | N/A |
| Humana Inc. (HUM)vs › | $47.80B | N/A |
| Cencora, Inc. (COR)vs › | $62.66B | N/A |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $44.86B | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $44.45B | N/A |
| Boston Scientific Corporation (BSX)vs › | $65.27B | N/A |
| Agilent Technologies, Inc. (A)vs › | $41.99B | N/A |
PEG Ratio
N/A
P/E Ratio
32.2
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute